LENZ Therapeutics, Inc. (LENZ) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at LENZ Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track LENZ on your watchlist.
Start for FreeAbout LENZ Therapeutics, Inc. Insider Trading
3 insiders at LENZ Therapeutics, Inc. (LENZ) have purchased stock in the past 90 days, totaling $366K across 3 transactions (41,181 shares).
The most recent purchase was by CFO Chevallard Daniel R. on March 27, 2026 — a $64K buy of 7,500 shares at $8.57, bringing his total holdings to 12,886 shares.
Insiders who purchased: Schimmelpennink Evert B. (CEO, 1 buy totaling $251K); Chevallard Daniel R. (CFO, 1 buy totaling $64K); George Jeffrey P. (Director, 1 buy totaling $50K).
This insider buying is notable given that LENZ had no recorded open market purchases in the nine months before that.
With 3 different insiders buying in the same 90-day window, this qualifies as cluster buying at LENZ — a pattern that research suggests can signal conviction among management.
Track LENZ insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.